Wei‐Ming Huang
-
- Cancer-related molecular mechanisms research 5
-
- Lung Cancer Diagnosis and Treatment 8
- Ferroptosis and cancer prognosis 4
- Pleural and Pulmonary Diseases 4
- Obstetrics and Gynecology top 10%
-
- RNA modifications and cancer 6
-
- Cardiovascular Function and Risk Factors 6
- Heart Failure Treatment and Management 4
-
- Radiomics and Machine Learning in Medical Imaging 4
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Wei‐Ming Huang
53 papers receiving 788 citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Cancer Research 116
- Pulmonary and Respiratory Medicine 189
- Obstetrics and Gynecology 45
- Epidemiology 196
- Reproductive Medicine 38
Countries citing papers authored by Wei‐Ming Huang
This map shows the geographic impact of Wei‐Ming Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ming Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ming Huang more than expected).
Fields of papers citing papers by Wei‐Ming Huang
This network shows the impact of papers produced by Wei‐Ming Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ming Huang. The network helps show where Wei‐Ming Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei‐Ming Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 6 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 8 | |
| 10 | 2021 | 19 | |
| 11 | 2021 | 8 | |
| 12 | 2021 | 3 | |
| 13 | 2021 | 5 | |
| 14 | 2019 | 18 | |
| 15 | 2019 | 9 | |
| 16 | 2018 | 6 | |
| 17 | 2018 | 7 | |
| 18 | 2016 | 0 | |
| 19 | [Dynamic road vehicle emission inventory simulation study based on real time traffic information]. | 2012 | 1 |
| 20 | 2012 | 10 |
About Wei‐Ming Huang
Wei‐Ming Huang is a scholar working on Microbiology, Pulmonary and Respiratory Medicine and Issues, ethics and legal aspects, having authored 64 papers that have together received 803 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (8 papers), RNA modifications and cancer (6 papers), Cardiovascular Function and Risk Factors (6 papers), Cancer-related molecular mechanisms research (5 papers), Heart Failure Treatment and Management (4 papers), Ferroptosis and cancer prognosis (4 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Pleural and Pulmonary Diseases (4 papers). The work is most often cited by research in Cancer Research (116 citations), Pulmonary and Respiratory Medicine (189 citations) and Obstetrics and Gynecology (45 citations). Wei‐Ming Huang has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Shujie Liao, Yuehan Li, R. Wang, Wei Pan, Chun Gao, Jin Lei, Ding Ma, Di Wu, Shih‐Hsien Sung and Chen‐Huan Chen. Their work appears in journals such as Scientific Reports, Cancers, Cancer Letters, Aging and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.